June 13th, 2024

Agreement to grant Université Laval an exclusive licence option for the commercial exploitation of aminosteroid derivatives.

June 13th, 2024

Obtained funding from the MITACS ELEVATION programme to support new work on aminosteroid derivatives.

June 13th, 2024

Obtained funding from the Programme de soutien aux organismes (PSO) of the Ministère de l’Économie, de l’Innovation et de l’Énergie.

June 13th, 2024

Neolys Pharma launches its brand new website